ArticleJournal of acquired immune deficiency syndromes (1999)2014

Clinical impact and cost-effectiveness of making third-line antiretroviral therapy available in sub-Saharan Africa: a model-based analysis in Côte d'Ivoire.

Eric N Ouattara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.